PD47-09 FIRST SURVIVAL OUTCOMES AND ADDITIONAL SECONDARY ANALYSES FROM PURE-01: PEMBROLIZUMAB (PEMBRO) BEFORE RADICAL CYSTECTOMY (RC) IN MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC) | Zendy

AI Assistant Blog Pricing

PD47-09 FIRST SURVIVAL OUTCOMES AND ADDITIONAL SECONDARY ANALYSES FROM PURE-01: PEMBROLIZUMAB (PEMBRO) BEFORE RADICAL CYSTECTOMY (RC) IN MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.